STAAR Surgical Company recently issued preliminary guidance indicating net sales for the second quarter of 2026 are expected ...

What Happened? A number of stocks fell in the afternoon session after a key industry player warned that changes to some ...

As of Monday, July 20, STAAR Surgical Company’s STAA share price has dipped by 5.03%, which has investors questioning if this ...

Staar Surgical (NASDAQ:STAA) will release its quarterly earnings report on Wednesday, 2024-10-30. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Staar Surgical to ...

STAAR Surgical (STAA) stock drops as concerns over outlook overshadow the company's better-than-expected preliminary sales ...

STAAR Surgical has had an impressive run over the past six months as its shares have beaten the S&P 500 by 7.7%. The stock now trades at $27.81, marking a 16.2% gain. This was partly thanks to its ...

STAAR Surgical Company STAA stock is trading lower on Friday after reporting preliminary net sales for the second quarter of ...

Detailed price information for Staar Surgical Company (STAA-Q) from The Globe and Mail including charting and trades.

Sand Grove's new position in STAAR Surgical represents 10.88% of its 13F assets as of September 30. Top five holdings following the filing: NYSE:TXNM: $33.54 million (16.4% of AUM) NYSE:K: $26.73 ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL) today announced that Alcon (SIX/NYSE: ALC) has exercised its right ...

5 analysts have shared their evaluations of Staar Surgical (NASDAQ:STAA) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below provides a snapshot of ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, ...